Education
About Us
Working with TipRanks
Follow Us
Marpai (MRAI)
OTHER OTC:MRAI
MRAI Stock Chart & Stats
$0.73
-$0.08(-7.69%)
At close: 4:00 PM EST
$0.73
-$0.08(-7.69%)
Day’s Range― - ―
52-Week Range$0.36 - $1.78
Previous CloseN/A
Volume51.03K
Average Volume (3M)20.43K
Market Cap
$9.41M
Enterprise Value$6.57M
Total Cash (Recent Filing)$445.00K
Total Debt (Recent Filing)$854.00K
Price to Earnings (P/E)―
Beta-0.74
Next Earnings
Apr 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.20
Shares Outstanding23,530,611
10 Day Avg. Volume21,648
30 Day Avg. Volume20,435
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.39
Price to Sales (P/S)0.39
P/FCF Ratio-0.72
Enterprise Value/Market Cap0.70
Enterprise Value/Revenue0.32
Enterprise Value/Gross Profit1.03
Enterprise Value/Ebitda-0.59
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Focused TPA Business ModelMarpai’s core TPA model targets self-funded employer plans, producing recurring fee-based revenue and operationally scalable services. This asset-light, administration-focused business can sustain revenue visibility and client stickiness over months, enabling margin improvement as client volumes grow.
Consolidated Claims PlatformMigrating claims processing to a single advanced system is a structural efficiency play. It reduces unit processing costs, speeds onboarding, and supports operational scalability. Over a multi-month horizon this can materially lower ongoing opex and improve operating leverage as revenue normalizes.
MarpaiRx Program DifferentiationMarpaiRx is a proprietary product that strengthens Marpai’s value proposition to employers by addressing pharmacy spend. Product differentiation aids new client wins and retention, creating a durable competitive edge that can reduce medical cost trends for clients and support long-term revenue stability.
Bears Say
Negative Shareholders' EquityMaterial negative equity signals a structurally weakened capital base and higher credit risk. It constrains access to non-dilutive financing, increases reliance on equity raises, and limits ability to invest in growth or weather revenue shocks, raising long-term financing and strategic risks.
Ongoing Cash BurnSustained negative operating and free cash flow means the business cannot self-fund operations and depends on external capital. Even with improvement versus prior years, ongoing burn raises refinancing risk and can force dilutive financings or curtailed strategic initiatives if capital access tightens.
Revenue Decline And Persistent LossesMulti-year revenue volatility and sizable operating losses show a lack of operating leverage. Declining top-line undermines scale economics needed to cover fixed costs; without sustained revenue recovery, margins and profitability will remain elusive and strategic turnaround timelines extend.
Marpai News
MRAI FAQ
What was Marpai’s price range in the past 12 months?
Marpai lowest stock price was $0.36 and its highest was $1.78 in the past 12 months.
What is Marpai’s market cap?
Marpai’s market cap is $9.41M.
When is Marpai’s upcoming earnings report date?
Marpai’s upcoming earnings report date is Apr 01, 2026 which is in 42 days.
How were Marpai’s earnings last quarter?
Marpai released its earnings results on Nov 12, 2025. The company reported -$0.2 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.2.
Is Marpai overvalued?
According to Wall Street analysts Marpai’s price is currently Overvalued.
Does Marpai pay dividends?
Marpai does not currently pay dividends.
What is Marpai’s EPS estimate?
Marpai’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Marpai have?
Marpai has 23,530,611 shares outstanding.
What happened to Marpai’s price movement after its last earnings report?
Marpai reported an EPS of -$0.2 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.84%.
Which hedge fund is a major shareholder of Marpai?
Currently, no hedge funds are holding shares in MRAI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Marpai
Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services. It also develops artificial intelligence and healthcare technology that enables the analysis of data to predict and prevent events related to diagnostic errors, hospital visits, and administrative issues. The company was incorporated in 2021 and is headquartered in New York, New York.
MRAI Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant operational improvements and strategic initiatives like cost reduction and new client acquisitions. However, the notable decline in net revenues and ongoing operating losses temper these achievements.View all MRAI earnings summariesTechnical Analysis
Ownership Overview
66.67% Insiders
0.09% Other Institutional Investors
33.24% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---